Drug intelligence / Profile preview

norethindrone + mestranol

Development stage
Unknown
Lead developer
Johnson & Johnson
Modality
Small Molecules
Administration
Oral
01

Overview

Norethindrone + mestranol is a combination oral contraceptive containing two types of female hormones: a progestin (norethindrone) and an estrogen (mestranol). This combination works primarily by inhibiting ovulation through suppression of the hypothalamic-pituitary-ovarian axis. Norethindrone acts as a synthetic progestational hormone, while mestranol is a synthetic estrogen that must be demethylated to become biologically active. Together, they alter the cervical mucus and endometrial lining to further prevent fertilization and implantation. The primary indication for this drug is contraception; it may also be used in certain cases for menstrual regulation or treatment of hormonal imbalances[1][2][4][7].

Brand names
Necon 1/50Norinyl 1/50Ortho-Novum 1/50
Other names
norethisterone + mestranol
02

Targets

SHBG (Sex hormone-binding globulin)PR (Progesterone receptor)AR (Adrenergic receptors)ER (Estrogen receptor)

Beyond the preview

Go deeper on norethindrone + mestranol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on norethindrone + mestranol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call